{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:44:34Z","timestamp":1770752674383,"version":"3.50.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.ymgme.2005.04.009","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T15:46:32Z","timestamp":1118418392000},"page":"255-259","source":"Crossref","is-referenced-by-count":68,"title":["Gastrointestinal manifestations of Fabry disease: Clinical response to enzyme replacement therapy"],"prefix":"10.1016","volume":"85","author":[{"given":"Maryam","family":"Banikazemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert. J.","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2005.04.009_bib1","series-title":"Metabolic and molecular bases of inherited disease","first-page":"3733","article-title":"Alpha-galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.ymgme.2005.04.009_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2005.04.009_bib3","first-page":"246","article-title":"Gastrointestinal structure and function in Fabry\u2019s disease","volume":"76","author":"Sheth","year":"1981","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ymgme.2005.04.009_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/B:BOLI.0000037342.59612.69","article-title":"Relief of gastrointestinal symptoms under enzyme replacement therapy in patients with Fabry disease","volume":"27","author":"Dehout","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2005.04.009_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1015009210639","article-title":"Assessment of health-related quality-of-life in males with Anderson Fabry Disease before therapeutic intervention","volume":"11","author":"Miners","year":"2002","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ymgme.2005.04.009_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1015511908710","article-title":"Quality of life of patients with Fabry disease","volume":"11","author":"Gold","year":"2002","journal-title":"Qual. Life Res."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2005.04.009_bib7","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/01.ASN.0000016683.73778.78","article-title":"Natural history and treatment of renal involvement in Fabry disease","volume":"13","author":"Branton","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2005.04.009_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2005.04.009_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000169023","article-title":"Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure","volume":"16","author":"Van Loo","year":"1996","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ymgme.2005.04.009_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2005.04.009_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a renal variant phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2005.04.009_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2005.04.009_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1445-5994.2002.00291.x","article-title":"Clinical features of Fabry\u2019s disease in Australian patients","volume":"32","author":"Galanos","year":"2002","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ymgme.2005.04.009_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000060196","article-title":"Clinical manifestation in female Fabry disease patients","author":"Whybra","year":"2001","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.ymgme.2005.04.009_bib15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/0003-4819-81-5-628","article-title":"Intestinal manifestations of Fabry\u2019s disease","volume":"81","author":"Rowe","year":"1974","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2005.04.009_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.32.5.498","article-title":"Fabry disease: impaired autonomic function","volume":"32","author":"Cable","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2005.04.009_bib17","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00006231-199809000-00009","article-title":"Gastrointestinal symptoms and delayed gastric emptying in Fabry\u2019s disease: response to metoclopramide","volume":"19","author":"Argoff","year":"1998","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ymgme.2005.04.009_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00000446-200104000-00019","article-title":"Fabry disease","volume":"101","author":"Stryker","year":"2001","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.ymgme.2005.04.009_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0016-5085(84)80028-1","article-title":"Jejunal diverticulosis with perforation as a complication of Fabry\u2019s disease","volume":"86","author":"Friedman","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymgme.2005.04.009_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005176-200102000-00020","article-title":"Achalasia in an adolescent with Fabry disease","volume":"32","author":"Field","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2005.04.009_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/014107688407700520","article-title":"Achalasia in Anderson-Fabry\u2019s disease","volume":"77","author":"Roberts","year":"1984","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.ymgme.2005.04.009_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2005.04.009_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2005.04.009_bib24","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2005.04.009_bib25","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.0022-202X.2004.22425.x","article-title":"Monitoring the 3-year efficacy of enzyme replacement therapy in Fabry disease by repeated skin biopsies","volume":"122","author":"Thurberg","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ymgme.2005.04.009_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2005.04.009_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2005.04.009_bib28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0016-5085(82)80262-X","article-title":"Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry\u2019s disease","volume":"82","author":"O\u2019Brien","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymgme.2005.04.009_bib29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00042737-200410000-00020","article-title":"Effect of enzyme-replacement therapy on gastrointestinal symptoms in Fabry disease","volume":"16","author":"Hoffmann","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymgme.2005.04.009_bib30","first-page":"7","article-title":"Fet\u00e1ln\u00ed\u0301 patologie Fabryho nemoci a mukopolysacharid\u00f3zy I [Fetal pathology in Fabry\u2019s disease and mucopolysaccharidosis type I]","volume":"34","author":"Elleder","year":"1998","journal-title":"Cesk. Patol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719205001356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719205001356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T13:50:15Z","timestamp":1706277015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719205001356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1096719205001356"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2005.04.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}